Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield.

IF 3.4 Q2 ONCOLOGY JNCI Cancer Spectrum Pub Date : 2024-04-30 DOI:10.1093/jncics/pkae043
Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg
{"title":"Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield.","authors":"Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg","doi":"10.1093/jncics/pkae043","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Socioeconomic inequalities in the uptake of colorectal cancer screening are well documented, but the implications on inequities in health gain remain unclear.</p><p><strong>Methods: </strong>Sixty-year-olds were randomly recruited from the Swedish population between March 2014 and March 2020 and invited to undergo either 2 rounds of fecal immunochemical testing (FIT) 2 years apart (n = 60 137) or primary colonoscopy just once (n = 30 400). By linkage to Statistics Sweden's registries, we obtained socioeconomic data. In each defined socioeconomic group, we estimated the cumulative yield of advanced neoplasia in each screening arm (intention-to-screen analysis). In the biennial FIT arm, we predicted the probability of exceeding the yield in the primary colonoscopy arm by linear extrapolation of the cumulative yield to (hypothetical) additional rounds of FIT.</p><p><strong>Results: </strong>In the lowest income group, the yield of advanced neoplasia was 1.63% (95% confidence interval [CI] = 1.35% to 1.93%) after 2 rounds of FIT vs 1.93% (95% CI = 1.49% to 2.40%) in the primary colonoscopy arm. Extrapolation to a third round of FIT implied a 86% probability of exceeding the yield in the primary colonoscopy arm. In the highest income group, we found a more pronounced yield gap between the 2 screening strategies-2.32% (95% CI = 2.15% to 2.49%) vs 3.71% (95% CI = 3.41% to 4.02%)- implying a low (2%) predicted probability of exceeding yield after a third round of FIT.</p><p><strong>Conclusions: </strong>Yield of advanced neoplasia from 2 rounds of FIT 2 years apart was poorer as compared with primary colonoscopy, but the difference was less in lower socioeconomic groups.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov identifier NCT02078804.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11187582/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkae043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Socioeconomic inequalities in the uptake of colorectal cancer screening are well documented, but the implications on inequities in health gain remain unclear.

Methods: Sixty-year-olds were randomly recruited from the Swedish population between March 2014 and March 2020 and invited to undergo either 2 rounds of fecal immunochemical testing (FIT) 2 years apart (n = 60 137) or primary colonoscopy just once (n = 30 400). By linkage to Statistics Sweden's registries, we obtained socioeconomic data. In each defined socioeconomic group, we estimated the cumulative yield of advanced neoplasia in each screening arm (intention-to-screen analysis). In the biennial FIT arm, we predicted the probability of exceeding the yield in the primary colonoscopy arm by linear extrapolation of the cumulative yield to (hypothetical) additional rounds of FIT.

Results: In the lowest income group, the yield of advanced neoplasia was 1.63% (95% confidence interval [CI] = 1.35% to 1.93%) after 2 rounds of FIT vs 1.93% (95% CI = 1.49% to 2.40%) in the primary colonoscopy arm. Extrapolation to a third round of FIT implied a 86% probability of exceeding the yield in the primary colonoscopy arm. In the highest income group, we found a more pronounced yield gap between the 2 screening strategies-2.32% (95% CI = 2.15% to 2.49%) vs 3.71% (95% CI = 3.41% to 4.02%)- implying a low (2%) predicted probability of exceeding yield after a third round of FIT.

Conclusions: Yield of advanced neoplasia from 2 rounds of FIT 2 years apart was poorer as compared with primary colonoscopy, but the difference was less in lower socioeconomic groups.

Clinical trial registration: ClinicalTrials.gov identifier NCT02078804.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
采用粪便免疫化学检验或初级结肠镜检查进行结直肠癌筛查:诊断率的不平等。
背景:在接受结直肠癌筛查方面存在的社会经济不平等已被充分记录在案,但其对健康不平等的影响仍不清楚:在 2014 年 3 月至 2020 年 3 月期间,我们从瑞典人口中随机招募了 60 岁的人,并邀请他们接受间隔 2 年的粪便免疫化学检测 (FIT)(n = 60,137 人)或仅一次的初级结肠镜检查 (PCOL;n = 30,400 人)。通过与瑞典统计局登记处的链接,我们获得了社会经济数据。在每个确定的社会经济组中,我们估算了每个筛查组的晚期肿瘤(AN)累积发病率(意向筛查分析)。我们预测了第三轮 FIT 后 PCOL 组超过筛查率的概率:Pr{AN_FIT3>AN_PCOL}:结果:在最低收入组中,两轮 FIT 后 AN 感染率为 1.63%(95% 置信区间 [CI] = 1.35% 至 1.93%),而 PCOL 组为 1.93%(95% 置信区间 [CI] = 1.49% 至 2.40%)。我们预测 Pr{AN_FIT3>AN_PCOL} = 0.86。在最高收入组中,我们发现两种筛查策略的收益差距更为明显,分别为 2.32% (95% CI = 2.15% to 2.49%) vs 3.71% (95% CI = 3.41% to 4.02%),且 Pr{AN_FIT3>AN_PCOL} 很低 (= 0.02)。(= 0.02):在社会经济地位较低的群体中,相隔 2 年的 FIT 和 PCOL 分别产生的 AN 值较低,但差异较小。这些结果对评估有组织的大肠癌筛查中的健康公平性很有价值:临床试验注册:ClinicalTrials.gov 编号 NCT02078804。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JNCI Cancer Spectrum
JNCI Cancer Spectrum Medicine-Oncology
CiteScore
7.70
自引率
0.00%
发文量
80
审稿时长
18 weeks
期刊最新文献
Association between GLP-1RA use and progression of MGUS to Multiple Myeloma among diabetic patients. Sexual Function and Satisfaction in Young Women with Breast Cancer: A Five-Year Prospective Study. County-level racial disparities in prostate cancer specific mortality from 2005 to 2020. Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis. Neighborhood vulnerability and associations with poor health-related quality of life among adult survivors of childhood cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1